Bereczky, Zsuzsanna

Link to this page

Authority KeyName Variants
b5b77bf9-769a-4c95-ba54-d1d2978b16ad
  • Bereczky, Zsuzsanna (6)
Projects

Author's Bibliography

The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications

Kovač, Mirjana; Mitić, Gorana; Miković, Zeljko; Mandić, Vesna; Miljić, Predrag; Mitrović, Mirjana; Tomić, Branko; Bereczky, Zsuzsanna

(Pergamon-Elsevier Science Ltd, Oxford, 2019)

TY  - JOUR
AU  - Kovač, Mirjana
AU  - Mitić, Gorana
AU  - Miković, Zeljko
AU  - Mandić, Vesna
AU  - Miljić, Predrag
AU  - Mitrović, Mirjana
AU  - Tomić, Branko
AU  - Bereczky, Zsuzsanna
PY  - 2019
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/1287
AB  - Background: Inherited antithrombin (AT) deficiency is a rare autosomal dominant disorder, caused by mutations in the SERPINC1 gene. The most common clinical presentation in AT deficient patients includes venous thrombosis and pulmonary embolism, while the association of AT deficiency and its effect on the development of pregnancy complications has been less studied. The aim of our research was to evaluate the effect of AT deficiency types, determined by genotyping, on pregnancy outcomes. Methods: A retrospective cohort study included 28 women with AT deficiency, and their 64 pregnancies were analyzed. Results: With regard to live birth rate, a significant difference was observed among women who were carriers of different SERPINC1 mutations, as the rate varied from 100% in cases of type I to the extremely low rate of 8% for women with type II HBS (AT Budapest 3) in the homozygous variant, P=0.0005. All pregnancies from the type I group, even untreated ones, resulted in live births. In women with AT Budapest 3 in homozygous variant the overall live birth rate increased to 28.5% in the treated pregnancies. In this group the highest incidence of fetal death was observed of 62%; repeated fetal losses in 30%; fetal growth restriction in 22% and placental abruption in 7% of all pregnancies. Conclusion: Our study results indicate a difference between type I and type II AT deficiency. The risk of pregnancy related VTE was equally present in both groups, except for AT Budapest 3 in the heterozygous variant, while adverse pregnancy outcomes were strictly related to type II, especially AT Budapest 3 in the homozygous variant.
PB  - Pergamon-Elsevier Science Ltd, Oxford
T2  - Thrombosis Research
T1  - The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications
EP  - 19
SP  - 12
VL  - 173
DO  - 10.1016/j.thromres.2018.11.006
ER  - 
@article{
author = "Kovač, Mirjana and Mitić, Gorana and Miković, Zeljko and Mandić, Vesna and Miljić, Predrag and Mitrović, Mirjana and Tomić, Branko and Bereczky, Zsuzsanna",
year = "2019",
abstract = "Background: Inherited antithrombin (AT) deficiency is a rare autosomal dominant disorder, caused by mutations in the SERPINC1 gene. The most common clinical presentation in AT deficient patients includes venous thrombosis and pulmonary embolism, while the association of AT deficiency and its effect on the development of pregnancy complications has been less studied. The aim of our research was to evaluate the effect of AT deficiency types, determined by genotyping, on pregnancy outcomes. Methods: A retrospective cohort study included 28 women with AT deficiency, and their 64 pregnancies were analyzed. Results: With regard to live birth rate, a significant difference was observed among women who were carriers of different SERPINC1 mutations, as the rate varied from 100% in cases of type I to the extremely low rate of 8% for women with type II HBS (AT Budapest 3) in the homozygous variant, P=0.0005. All pregnancies from the type I group, even untreated ones, resulted in live births. In women with AT Budapest 3 in homozygous variant the overall live birth rate increased to 28.5% in the treated pregnancies. In this group the highest incidence of fetal death was observed of 62%; repeated fetal losses in 30%; fetal growth restriction in 22% and placental abruption in 7% of all pregnancies. Conclusion: Our study results indicate a difference between type I and type II AT deficiency. The risk of pregnancy related VTE was equally present in both groups, except for AT Budapest 3 in the heterozygous variant, while adverse pregnancy outcomes were strictly related to type II, especially AT Budapest 3 in the homozygous variant.",
publisher = "Pergamon-Elsevier Science Ltd, Oxford",
journal = "Thrombosis Research",
title = "The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications",
pages = "19-12",
volume = "173",
doi = "10.1016/j.thromres.2018.11.006"
}
Kovač, M., Mitić, G., Miković, Z., Mandić, V., Miljić, P., Mitrović, M., Tomić, B.,& Bereczky, Z.. (2019). The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications. in Thrombosis Research
Pergamon-Elsevier Science Ltd, Oxford., 173, 12-19.
https://doi.org/10.1016/j.thromres.2018.11.006
Kovač M, Mitić G, Miković Z, Mandić V, Miljić P, Mitrović M, Tomić B, Bereczky Z. The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications. in Thrombosis Research. 2019;173:12-19.
doi:10.1016/j.thromres.2018.11.006 .
Kovač, Mirjana, Mitić, Gorana, Miković, Zeljko, Mandić, Vesna, Miljić, Predrag, Mitrović, Mirjana, Tomić, Branko, Bereczky, Zsuzsanna, "The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications" in Thrombosis Research, 173 (2019):12-19,
https://doi.org/10.1016/j.thromres.2018.11.006 . .
1
19
1
19

Genotype phenotype correlation in a pediatric population with antithrombin deficiency

Kovač, Mirjana; Mitić, Gorana; Đilas, Iva; Kuzmanović, Milos; Serbić, Olivera; Leković, Danijela; Tomić, Branko; Bereczky, Zsuzsanna

(Springer, New York, 2019)

TY  - JOUR
AU  - Kovač, Mirjana
AU  - Mitić, Gorana
AU  - Đilas, Iva
AU  - Kuzmanović, Milos
AU  - Serbić, Olivera
AU  - Leković, Danijela
AU  - Tomić, Branko
AU  - Bereczky, Zsuzsanna
PY  - 2019
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/1208
AB  - Inherited antithrombin (AT) deficiency is a rare autosomal dominant disorder, caused by mutations in the AT gene (SERPINC1). Considering that the genotype phenotype relationship in AT deficiency patients remains unclear, especially in pediatric patients, the aim of our study was to evaluate genotype phenotype correlation in a Serbian pediatric population. A retrospective cohort study included 19 children younger than 18 years, from 15 Serbian families, with newly diagnosed AT deficiency. In 21% of the recruited families, mutations affecting exon 4, 5, and 6 of the SERPINC1 gene that causes type I AT deficiency were detected. In the remaining families, the mutation in exon 2 causing type II HBS (AT Budapest 3) was found. Thrombosis events were observed in 1 (33%) of those with type I, 11 (85%) of those with AT Budapest 3 in the homozygous respectively, and 1(33%) in the heterozygous form. Recurrent thrombosis was observed only in AT Budapest 3 in the homozygous form, in 27% during initial treatment of the first thrombotic event. Abdominal venous thrombosis and arterial ischemic stroke, observed in almost half of the children from the group with AT Budapest 3 in the homozygous form, were unprovoked in all cases. Conclusion: Type II HBS (AT Budapest 3) in the homozygous form is a strong risk factor for arterial and venous thrombosis in pediatric patients.What is Known:center dot Inherited AT deficiency is a rare autosomal dominant disorder, caused by mutations in the SERPINC1gene.center dot The genotype phenotype correlation in AT deficiency patients remains unclear, especially in pediatric patients.What is New:center dot The genetic results for our paediatric population predominantly showed the presence of a single specific mutation in exon 2, that causes type II HBS deficiency (AT Budapest 3).center dot In this group thrombosis mostly occurred as unprovoked, in almost half of them as abdominal thrombosis or stroke with high incidence of recurrent thrombosis, in 27% during initial treatment.
PB  - Springer, New York
T2  - European Journal of Pediatrics
T1  - Genotype phenotype correlation in a pediatric population with antithrombin deficiency
EP  - 1478
IS  - 10
SP  - 1471
VL  - 178
DO  - 10.1007/s00431-019-03433-5
ER  - 
@article{
author = "Kovač, Mirjana and Mitić, Gorana and Đilas, Iva and Kuzmanović, Milos and Serbić, Olivera and Leković, Danijela and Tomić, Branko and Bereczky, Zsuzsanna",
year = "2019",
abstract = "Inherited antithrombin (AT) deficiency is a rare autosomal dominant disorder, caused by mutations in the AT gene (SERPINC1). Considering that the genotype phenotype relationship in AT deficiency patients remains unclear, especially in pediatric patients, the aim of our study was to evaluate genotype phenotype correlation in a Serbian pediatric population. A retrospective cohort study included 19 children younger than 18 years, from 15 Serbian families, with newly diagnosed AT deficiency. In 21% of the recruited families, mutations affecting exon 4, 5, and 6 of the SERPINC1 gene that causes type I AT deficiency were detected. In the remaining families, the mutation in exon 2 causing type II HBS (AT Budapest 3) was found. Thrombosis events were observed in 1 (33%) of those with type I, 11 (85%) of those with AT Budapest 3 in the homozygous respectively, and 1(33%) in the heterozygous form. Recurrent thrombosis was observed only in AT Budapest 3 in the homozygous form, in 27% during initial treatment of the first thrombotic event. Abdominal venous thrombosis and arterial ischemic stroke, observed in almost half of the children from the group with AT Budapest 3 in the homozygous form, were unprovoked in all cases. Conclusion: Type II HBS (AT Budapest 3) in the homozygous form is a strong risk factor for arterial and venous thrombosis in pediatric patients.What is Known:center dot Inherited AT deficiency is a rare autosomal dominant disorder, caused by mutations in the SERPINC1gene.center dot The genotype phenotype correlation in AT deficiency patients remains unclear, especially in pediatric patients.What is New:center dot The genetic results for our paediatric population predominantly showed the presence of a single specific mutation in exon 2, that causes type II HBS deficiency (AT Budapest 3).center dot In this group thrombosis mostly occurred as unprovoked, in almost half of them as abdominal thrombosis or stroke with high incidence of recurrent thrombosis, in 27% during initial treatment.",
publisher = "Springer, New York",
journal = "European Journal of Pediatrics",
title = "Genotype phenotype correlation in a pediatric population with antithrombin deficiency",
pages = "1478-1471",
number = "10",
volume = "178",
doi = "10.1007/s00431-019-03433-5"
}
Kovač, M., Mitić, G., Đilas, I., Kuzmanović, M., Serbić, O., Leković, D., Tomić, B.,& Bereczky, Z.. (2019). Genotype phenotype correlation in a pediatric population with antithrombin deficiency. in European Journal of Pediatrics
Springer, New York., 178(10), 1471-1478.
https://doi.org/10.1007/s00431-019-03433-5
Kovač M, Mitić G, Đilas I, Kuzmanović M, Serbić O, Leković D, Tomić B, Bereczky Z. Genotype phenotype correlation in a pediatric population with antithrombin deficiency. in European Journal of Pediatrics. 2019;178(10):1471-1478.
doi:10.1007/s00431-019-03433-5 .
Kovač, Mirjana, Mitić, Gorana, Đilas, Iva, Kuzmanović, Milos, Serbić, Olivera, Leković, Danijela, Tomić, Branko, Bereczky, Zsuzsanna, "Genotype phenotype correlation in a pediatric population with antithrombin deficiency" in European Journal of Pediatrics, 178, no. 10 (2019):1471-1478,
https://doi.org/10.1007/s00431-019-03433-5 . .
1
6
1
6

Evaluation of endogenous thrombin potential among patients with antithrombin deficiency

Kovač, Mirjana; Mitić, Gorana; Lalić-Cosić, Sanja; Đorđević, Valentina; Tomić, Branko; Muszbek, Laszlo; Bereczky, Zsuzsanna

(Pergamon-Elsevier Science Ltd, Oxford, 2018)

TY  - JOUR
AU  - Kovač, Mirjana
AU  - Mitić, Gorana
AU  - Lalić-Cosić, Sanja
AU  - Đorđević, Valentina
AU  - Tomić, Branko
AU  - Muszbek, Laszlo
AU  - Bereczky, Zsuzsanna
PY  - 2018
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/1108
PB  - Pergamon-Elsevier Science Ltd, Oxford
T2  - Thrombosis Research
T1  - Evaluation of endogenous thrombin potential among patients with antithrombin deficiency
EP  - 53
SP  - 50
VL  - 166
DO  - 10.1016/j.thromres.2018.04.004
ER  - 
@article{
author = "Kovač, Mirjana and Mitić, Gorana and Lalić-Cosić, Sanja and Đorđević, Valentina and Tomić, Branko and Muszbek, Laszlo and Bereczky, Zsuzsanna",
year = "2018",
publisher = "Pergamon-Elsevier Science Ltd, Oxford",
journal = "Thrombosis Research",
title = "Evaluation of endogenous thrombin potential among patients with antithrombin deficiency",
pages = "53-50",
volume = "166",
doi = "10.1016/j.thromres.2018.04.004"
}
Kovač, M., Mitić, G., Lalić-Cosić, S., Đorđević, V., Tomić, B., Muszbek, L.,& Bereczky, Z.. (2018). Evaluation of endogenous thrombin potential among patients with antithrombin deficiency. in Thrombosis Research
Pergamon-Elsevier Science Ltd, Oxford., 166, 50-53.
https://doi.org/10.1016/j.thromres.2018.04.004
Kovač M, Mitić G, Lalić-Cosić S, Đorđević V, Tomić B, Muszbek L, Bereczky Z. Evaluation of endogenous thrombin potential among patients with antithrombin deficiency. in Thrombosis Research. 2018;166:50-53.
doi:10.1016/j.thromres.2018.04.004 .
Kovač, Mirjana, Mitić, Gorana, Lalić-Cosić, Sanja, Đorđević, Valentina, Tomić, Branko, Muszbek, Laszlo, Bereczky, Zsuzsanna, "Evaluation of endogenous thrombin potential among patients with antithrombin deficiency" in Thrombosis Research, 166 (2018):50-53,
https://doi.org/10.1016/j.thromres.2018.04.004 . .
4
2

Early onset of abdominal venous thrombosis in a newborn with homozygous type II heparin-binding site antithrombin deficiency

Kovač, Mirjana; Mitić, Gorana; Jesić, Milos; Đorđević, Valentina; Muszbek, Laszlo; Bereczky, Zsuzsanna

(Lippincott Williams & Wilkins, Philadelphia, 2017)

TY  - JOUR
AU  - Kovač, Mirjana
AU  - Mitić, Gorana
AU  - Jesić, Milos
AU  - Đorđević, Valentina
AU  - Muszbek, Laszlo
AU  - Bereczky, Zsuzsanna
PY  - 2017
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/1072
AB  - The overall incidence of thromboembolic events in the neonatal period is 5 per 100 000 births, wherein more than 40% of all such manifestations are symptomatic renal vein thromboses. We describe the case of a newborn female who developed extensive thrombosis, which filled the inferior vena cava and renal vein and was diagnosed in the first weeks of life. A homozygous type II heparin-binding site antithrombin deficiency (c.391C gt T, p.Leu131Phe) was detected in the background. Despite the timely diagnosis and appropriate treatment, clinical signs of renal insufficiency, because of left kidney atrophy and arterial hypertension, were observed. Our case demonstrates the seriousness of the consequences arising after early onset of venous thrombosis caused by homozygous type II heparin-binding site antithrombin deficiency. In addition to prompt diagnosis, of huge importance is the determination of inherited thrombophilia, as it significantly affects therapeutic treatment and indicates that long-term follow-up is mandatory.
PB  - Lippincott Williams & Wilkins, Philadelphia
T2  - Blood Coagulation & Fibrinolysis
T1  - Early onset of abdominal venous thrombosis in a newborn with homozygous type II heparin-binding site antithrombin deficiency
EP  - 266
IS  - 3
SP  - 264
VL  - 28
DO  - 10.1097/MBC.0000000000000570
ER  - 
@article{
author = "Kovač, Mirjana and Mitić, Gorana and Jesić, Milos and Đorđević, Valentina and Muszbek, Laszlo and Bereczky, Zsuzsanna",
year = "2017",
abstract = "The overall incidence of thromboembolic events in the neonatal period is 5 per 100 000 births, wherein more than 40% of all such manifestations are symptomatic renal vein thromboses. We describe the case of a newborn female who developed extensive thrombosis, which filled the inferior vena cava and renal vein and was diagnosed in the first weeks of life. A homozygous type II heparin-binding site antithrombin deficiency (c.391C gt T, p.Leu131Phe) was detected in the background. Despite the timely diagnosis and appropriate treatment, clinical signs of renal insufficiency, because of left kidney atrophy and arterial hypertension, were observed. Our case demonstrates the seriousness of the consequences arising after early onset of venous thrombosis caused by homozygous type II heparin-binding site antithrombin deficiency. In addition to prompt diagnosis, of huge importance is the determination of inherited thrombophilia, as it significantly affects therapeutic treatment and indicates that long-term follow-up is mandatory.",
publisher = "Lippincott Williams & Wilkins, Philadelphia",
journal = "Blood Coagulation & Fibrinolysis",
title = "Early onset of abdominal venous thrombosis in a newborn with homozygous type II heparin-binding site antithrombin deficiency",
pages = "266-264",
number = "3",
volume = "28",
doi = "10.1097/MBC.0000000000000570"
}
Kovač, M., Mitić, G., Jesić, M., Đorđević, V., Muszbek, L.,& Bereczky, Z.. (2017). Early onset of abdominal venous thrombosis in a newborn with homozygous type II heparin-binding site antithrombin deficiency. in Blood Coagulation & Fibrinolysis
Lippincott Williams & Wilkins, Philadelphia., 28(3), 264-266.
https://doi.org/10.1097/MBC.0000000000000570
Kovač M, Mitić G, Jesić M, Đorđević V, Muszbek L, Bereczky Z. Early onset of abdominal venous thrombosis in a newborn with homozygous type II heparin-binding site antithrombin deficiency. in Blood Coagulation & Fibrinolysis. 2017;28(3):264-266.
doi:10.1097/MBC.0000000000000570 .
Kovač, Mirjana, Mitić, Gorana, Jesić, Milos, Đorđević, Valentina, Muszbek, Laszlo, Bereczky, Zsuzsanna, "Early onset of abdominal venous thrombosis in a newborn with homozygous type II heparin-binding site antithrombin deficiency" in Blood Coagulation & Fibrinolysis, 28, no. 3 (2017):264-266,
https://doi.org/10.1097/MBC.0000000000000570 . .
1
8
1
7

Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency

Kovač, Mirjana; Mitić, Gorana; Miković, Zeljko; Mandić, Vesna; Đorđević, Valentina; Muszbek, Laszlo; Bereczky, Zsuzsanna

(Pergamon-Elsevier Science Ltd, Oxford, 2016)

TY  - JOUR
AU  - Kovač, Mirjana
AU  - Mitić, Gorana
AU  - Miković, Zeljko
AU  - Mandić, Vesna
AU  - Đorđević, Valentina
AU  - Muszbek, Laszlo
AU  - Bereczky, Zsuzsanna
PY  - 2016
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/990
PB  - Pergamon-Elsevier Science Ltd, Oxford
T2  - Thrombosis Research
T1  - Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency
EP  - 113
SP  - 111
VL  - 139
DO  - 10.1016/j.thromres.2016.01.018
ER  - 
@article{
author = "Kovač, Mirjana and Mitić, Gorana and Miković, Zeljko and Mandić, Vesna and Đorđević, Valentina and Muszbek, Laszlo and Bereczky, Zsuzsanna",
year = "2016",
publisher = "Pergamon-Elsevier Science Ltd, Oxford",
journal = "Thrombosis Research",
title = "Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency",
pages = "113-111",
volume = "139",
doi = "10.1016/j.thromres.2016.01.018"
}
Kovač, M., Mitić, G., Miković, Z., Mandić, V., Đorđević, V., Muszbek, L.,& Bereczky, Z.. (2016). Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency. in Thrombosis Research
Pergamon-Elsevier Science Ltd, Oxford., 139, 111-113.
https://doi.org/10.1016/j.thromres.2016.01.018
Kovač M, Mitić G, Miković Z, Mandić V, Đorđević V, Muszbek L, Bereczky Z. Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency. in Thrombosis Research. 2016;139:111-113.
doi:10.1016/j.thromres.2016.01.018 .
Kovač, Mirjana, Mitić, Gorana, Miković, Zeljko, Mandić, Vesna, Đorđević, Valentina, Muszbek, Laszlo, Bereczky, Zsuzsanna, "Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency" in Thrombosis Research, 139 (2016):111-113,
https://doi.org/10.1016/j.thromres.2016.01.018 . .
6
2
6

Poor pregnancy outcome in women with homozygous type-II HBS antithrombin deficiency

Kovač, Mirjana; Mitić, Gorana; Miljić, Predrag; Miković, Zeljko; Mandić, Vesna; Đorđević, Valentina; Radojković, Dragica; Bereczky, Zsuzsanna; Muszbek, Laszlo

(Pergamon-Elsevier Science Ltd, Oxford, 2014)

TY  - JOUR
AU  - Kovač, Mirjana
AU  - Mitić, Gorana
AU  - Miljić, Predrag
AU  - Miković, Zeljko
AU  - Mandić, Vesna
AU  - Đorđević, Valentina
AU  - Radojković, Dragica
AU  - Bereczky, Zsuzsanna
AU  - Muszbek, Laszlo
PY  - 2014
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/722
PB  - Pergamon-Elsevier Science Ltd, Oxford
T2  - Thrombosis Research
T1  - Poor pregnancy outcome in women with homozygous type-II HBS antithrombin deficiency
EP  - 1160
IS  - 6
SP  - 1158
VL  - 133
DO  - 10.1016/j.thromres.2014.03.025
ER  - 
@article{
author = "Kovač, Mirjana and Mitić, Gorana and Miljić, Predrag and Miković, Zeljko and Mandić, Vesna and Đorđević, Valentina and Radojković, Dragica and Bereczky, Zsuzsanna and Muszbek, Laszlo",
year = "2014",
publisher = "Pergamon-Elsevier Science Ltd, Oxford",
journal = "Thrombosis Research",
title = "Poor pregnancy outcome in women with homozygous type-II HBS antithrombin deficiency",
pages = "1160-1158",
number = "6",
volume = "133",
doi = "10.1016/j.thromres.2014.03.025"
}
Kovač, M., Mitić, G., Miljić, P., Miković, Z., Mandić, V., Đorđević, V., Radojković, D., Bereczky, Z.,& Muszbek, L.. (2014). Poor pregnancy outcome in women with homozygous type-II HBS antithrombin deficiency. in Thrombosis Research
Pergamon-Elsevier Science Ltd, Oxford., 133(6), 1158-1160.
https://doi.org/10.1016/j.thromres.2014.03.025
Kovač M, Mitić G, Miljić P, Miković Z, Mandić V, Đorđević V, Radojković D, Bereczky Z, Muszbek L. Poor pregnancy outcome in women with homozygous type-II HBS antithrombin deficiency. in Thrombosis Research. 2014;133(6):1158-1160.
doi:10.1016/j.thromres.2014.03.025 .
Kovač, Mirjana, Mitić, Gorana, Miljić, Predrag, Miković, Zeljko, Mandić, Vesna, Đorđević, Valentina, Radojković, Dragica, Bereczky, Zsuzsanna, Muszbek, Laszlo, "Poor pregnancy outcome in women with homozygous type-II HBS antithrombin deficiency" in Thrombosis Research, 133, no. 6 (2014):1158-1160,
https://doi.org/10.1016/j.thromres.2014.03.025 . .
11
8
11